Daiichi Sankyo turns Kitasato vaccine joint venture into wholly owned subsidiary

Daiichi Sankyo acquired 6.7 % of shares of Kitasato Daiichi Sankyo Vaccine owned by Kitasato, making it a fully owned subsidiary.

Daiichi Sanky news release, December 1, 2017

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny